BIG 2024 | What are the Exit Strategies for Deeptechs?

Anthony Paronneau focuses his practice on a broad range of corporate and transactional matters, with a particular focus on the pharmaceutical, medical device, biotech, and healthcare sectors.

He has extensive experience representing life sciences companies, private equity funds, and venture capital firms in complex M&A and private equity transactions, including acquisitions, venture financings, joint ventures, and divestitures.

Anthony regularly advises emerging growth companies and VC investors on the structuring and negotiation of early- and late-stage funding rounds, and has acted on numerous high-profile cross-border and domestic transactions involving leading innovators in the healthtech and biotech spaces.

In addition, he counsels life sciences clients on strategic partnerships, collaborations, licensing agreements, and distribution arrangements, supporting their growth and commercialization strategies across all stages of development.